Adjuvant rituximab after autologous peripheral blood stem cell transplant (APBSCT) results in delayed immune reconstitution without increase in infectious complications. Horwitz, S. M., Breslin, S., Negrin, R. S., Stockerl-Goldstein, K. E., JOHNSTON, L. J., Shizuru, J. A., Taylor, T., Brown, B. W., Blume, K. G., Horning, S. J. AMER SOC HEMATOLOGY. 2000: 384A–384A

View details for Web of Science ID 000165256101658